United Therapeutics Corporation
UTHR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $18 | $13 | $14 | $16 |
| - Cash | $1 | $2 | $2 | $2 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $17 | $11 | $12 | $15 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 0.1% | 0.5% | 7.9% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 87.4% | 89% | 88.4% | 89.7% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 57.9% | 54.7% | 48.2% | 57.6% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 42.4% | 38.8% | 40.6% | 40.9% |
| EPS Diluted | 7.16 | 6.41 | 6.63 | 6.19 |
| % Growth | 11.7% | -3.3% | 7.1% | – |
| Operating Cash Flow | $1 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |